PT  - JOURNAL ARTICLE
AU  - Valand, H.A.
AU  - Huda, F.
AU  - Tu, R.K.
TI  - Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know
AID  - 10.3174/ajnr.A6042
DP  - 2019 May 01
TA  - American Journal of Neuroradiology
PG  - 766--768
VI  - 40
IP  - 5
4099  - http://www.ajnr.org/content/40/5/766.short
4100  - http://www.ajnr.org/content/40/5/766.full
SO  - Am. J. Neuroradiol.2019 May 01; 40
AB  - SUMMARY: Chimeric antigen receptor T-cell therapy is an exciting and rapidly emerging “fifth pillar” treatment for hematologic cancers. Unique treatment-related toxicities and cost remain a major hindrance to its widespread application. The commonly faced challenges with this innovative therapy, its neurotoxicity, and manifestation on neuroimaging studies, are reviewed.CARchimeric antigen receptorCRScytokine release syndromeCRESCAR-T-cell–related encephalopathy syndrome